Skip to content

Effect of Kamsaharitaki on Bronchial Asthma

Validation of Standard Manufacturing procedure of Kamsaharitaki avaleha prepared by two different varieties of Haritaki and their comparative effect on Tamaka Shwasa, A Double Blind Randomized Clinical Trial.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030639
Enrollment
60
Registered
2021-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

Intervention1: Kamsahritaki Avaleha (Vijaya): Kamsahritaki Avaleha prepared by using Vijaya Haritaki will be given in sufficient quantity for oral intake for duration of 28 days and follow up will be

Sponsors

Director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with minimum 3 to 4 classical signs and symptoms of Tamaka Shwasa. 2. Mild persistent cases of asthma (as per WHO GINA guidelines) of duration more than 6 months.

Exclusion criteria

Exclusion criteria: 1. Age more than 60 years and below 18years. 2. Mild intermittent, moderated persistent, severe persistent to severe asthma. 3. Dyspnoea resulting from other diseases like left ventricular failure, COPD (chronic bronchitis, emphysema), upper respiratory tract obstruction, bronchiectasis, etc. 4. Patients on regular steroidal therapy, inhalers or bronchodilators. 5. Patients having pneumonia, tuberculosis, lung cancer, lung abscess and another such complicated conditions. 6. Patients having diabetes, hypertension, acute and chronic renal failure etc. conditions in which urination is markedly diminished or excessive were excluded. 7. HIV positive patients. 8. Pregnant/lactating mothers

Design outcomes

Primary

MeasureTime frame
1.To validate SMP of Kamsaharitaki Avaleha. 2.To validate therapeutic efficacy of Kamsaharitaki Avaleha. Timepoint: 28 days

Secondary

MeasureTime frame
To establish the role of two varieties(Abhaya and Vijaya) of Haritaki in Kamsaharitaki AvalehaTimepoint: 28 days

Countries

India

Contacts

Public ContactDr Pradeep Prajapati

All India Institute of Ayurveda

prajapati.pradeep1@gmail.com9818575845

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026